- Home
- FNLC vs SMTI Comparison
FNLC vs SMTI Comparison
Compare FNLC & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNLC
- SMTI
- Stock Information
- Founded
- FNLC 1864
- SMTI 1982
- Country
- FNLC United States
- SMTI United States
- Employees
- FNLC N/A
- SMTI N/A
- Industry
- FNLC Major Banks
- SMTI Medical/Dental Instruments
- Sector
- FNLC Finance
- SMTI Health Care
- Exchange
- FNLC Nasdaq
- SMTI Nasdaq
- Market Cap
- FNLC 263.4M
- SMTI 266.7M
- IPO Year
- FNLC 1999
- SMTI N/A
- Fundamental
- Price
- FNLC $24.19
- SMTI $29.00
- Analyst Decision
- FNLC
- SMTI Strong Buy
- Analyst Count
- FNLC 0
- SMTI 2
- Target Price
- FNLC N/A
- SMTI $49.50
- AVG Volume (30 Days)
- FNLC 14.3K
- SMTI 30.7K
- Earning Date
- FNLC 07-23-2025
- SMTI 05-14-2025
- Dividend Yield
- FNLC 5.95%
- SMTI N/A
- EPS Growth
- FNLC 1.61
- SMTI N/A
- EPS
- FNLC 2.52
- SMTI N/A
- Revenue
- FNLC $82,116,000.00
- SMTI $91,569,883.00
- Revenue This Year
- FNLC N/A
- SMTI $23.68
- Revenue Next Year
- FNLC N/A
- SMTI $5.80
- P/E Ratio
- FNLC $9.60
- SMTI N/A
- Revenue Growth
- FNLC 5.28
- SMTI 34.65
- 52 Week Low
- FNLC $22.11
- SMTI $25.86
- 52 Week High
- FNLC $31.05
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- FNLC 47.41
- SMTI 39.06
- Support Level
- FNLC $23.75
- SMTI $28.89
- Resistance Level
- FNLC $25.02
- SMTI $31.00
- Average True Range (ATR)
- FNLC 0.51
- SMTI 1.31
- MACD
- FNLC -0.06
- SMTI -0.37
- Stochastic Oscillator
- FNLC 38.97
- SMTI 14.27
About FNLC First Bancorp Inc (ME)
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.